The rating upgrade was based on a number of factors, including the hospital’s improved financial performance through the year-to-date period of fiscal year 2015, light leverage and limited capital needs.
“We think it is unlikely that we would raise the rating further within the two-year outlook period,” said Margaret McNamara, an S&P analyst. “We, however, could raise the rating over a longer period if management were to develop and clarify its long-term strategic plans, including potential partnerships, or if the financial profile were to improve, including sustaining margins of more than 3 percent and materially growing key balance sheet metrics to levels we consider consistent with ‘A’ medians.”
The hospital’s outlook is stable.
More articles on healthcare finance:
5 recent hospital bankruptcies
40 financial benchmarks for hospital executives
9 latest CFO moves in hospitals, health systems
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
